UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The cancer metabolic reprogramming and immune response

Molecular cancer, 2021-02, Vol.20 (1), p.28-28, Article 28

2021

Volltextzugriff (PDF)

PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer

Redox biology, 2021-06, Vol.42, p.101928-101928, Article 101928

2021

Volltextzugriff (PDF)

PARP inhibitor resistance: the underlying mechanisms and clinical implications

Molecular cancer, 2020-06, Vol.19 (1), p.107-107, Article 107

2020

Volltextzugriff (PDF)

Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential

Experimental and Molecular Medicine, 2023, 55(0), , pp.1357-1370

2023

Volltextzugriff (PDF)

TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling

Journal of experimental & clinical cancer research, 2019-02, Vol.38 (1), p.106-15, Article 106

2019

Volltextzugriff (PDF)

The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity

Oncogene, 2022-02, Vol.41 (7), p.1024-1039

2022

Volltextzugriff (PDF)

Development of a novel transcription factors-related prognostic signature for serous ovarian cancer

Scientific reports, 2021-03, Vol.11 (1), p.7207-7207, Article 7207

2021

Volltextzugriff (PDF)

Application of PARP inhibitors combined with immune checkpoint inhibitors in ovarian cancer

Journal of translational medicine, 2024-08, Vol.22 (1), p.778-17

2024

Volltextzugriff (PDF)

SOX2OT, a novel tumor-related long non-coding RNA

Biomedicine & pharmacotherapy, 2020-03, Vol.123, p.109725-109725, Article 109725

2020

Volltextzugriff (PDF)

TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation

Journal of experimental & clinical cancer research, 2022-01, Vol.41 (1), p.44-44, Article 44

2022

Volltextzugriff (PDF)

Rac1 promotes the reprogramming of glucose metabolism and the growth of colon cancer cells through upregulating SOX9

Cancer science, 2023-03, Vol.114 (3), p.822-836

2023

Volltextzugriff (PDF)

Correction: TRPM7 promotes the epithelial- mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling

Journal of experimental & clinical cancer research, 2024-10, Vol.43 (1), p.291-4, Article 291

2024

Volltextzugriff (PDF)

Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment

Journal of experimental & clinical cancer research, 2023-03, Vol.42 (1), p.59-59, Article 59

2023

Volltextzugriff (PDF)

Radiomic Score as a Potential Imaging Biomarker for Predicting Survival in Patients With Cervical Cancer

Frontiers in oncology, 2021-08, Vol.11, p.706043-706043

2021

Volltextzugriff (PDF)

Mendelian Randomization Study Supports Genetic Liability to Obsessive–Compulsive Disorder Associated With the Risk of Alzheimer's Disease

Brain and behavior, 2024-10, Vol.14 (10), p.e70081-n/a

2024

Volltextzugriff (PDF)

Cellular models of development of ovarian high‐grade serous carcinoma: A review of cell of origin and mechanisms of carcinogenesis

Cell proliferation, 2021-05, Vol.54 (5), p.e13029-n/a

2021

Volltextzugriff (PDF)

LPLUNC1 reduces glycolysis in nasopharyngeal carcinoma cells through the PHB1‐p53/c‐Myc axis

Cancer science, 2023-03, Vol.114 (3), p.870-884

2023

Volltextzugriff (PDF)

Circular RNA hsa_circ_0000467 promotes colorectal cancer progression by promoting eIF4A3-mediated c-Myc translation

Molecular cancer, 2024-07, Vol.23 (1), p.151-18, Article 151

2024

Volltextzugriff (PDF)

CSF3 Is a Potential Drug Target for the Treatment of COVID-19

Frontiers in physiology, 2021-01, Vol.11, p.605792

2021

Volltextzugriff (PDF)

Editorial: Ovarian cancer-targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more

Frontiers in pharmacology, 2023-06, Vol.14, p.1222209-1222209

2023

Volltextzugriff (PDF)

Identification and validation of an immune-related lncRNAs signature to predict the overall survival of ovarian cancer

Frontiers in oncology, 2022-10, Vol.12, p.999654-999654

2022

Volltextzugriff (PDF)

The function of prohibitins in mitochondria and the clinical potentials

Cancer cell international, 2022-11, Vol.22 (1), p.1-343, Article 343

2022

Volltextzugriff (PDF)

ZNF582 promoter methylation predicts cervical cancer radiosensitivity and ZNF582 protein overexpression reduces radiosensitivity by cell cycle arrest in S phase

Epigenetics, 2022-12, Vol.17 (12), p.1786-1799

2022

Volltextzugriff (PDF)

The roles and molecular mechanisms of non-coding RNA in cancer metabolic reprogramming

Cancer cell international, 2024-01, Vol.24 (1), p.37-37, Article 37

2024

Volltextzugriff (PDF)

Ferritinophagy: research advance and clinical significance in cancers

Cell death discovery, 2023-12, Vol.9 (1), p.463-463, Article 463

2023

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(47)

Sprache

Englisch
(47)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

The cancer metabolic reprogramming and immune response

PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer

PARP inhibitor resistance: the underlying mechanisms and clinical implications

Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential

TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling

The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity

Development of a novel transcription factors-related prognostic signature for serous ovarian cancer

Application of PARP inhibitors combined with immune checkpoint inhibitors in ovarian cancer

SOX2OT, a novel tumor-related long non-coding RNA

TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation

Rac1 promotes the reprogramming of glucose metabolism and the growth of colon cancer cells through upregulating SOX9

Correction: TRPM7 promotes the epithelial- mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling

Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment

Radiomic Score as a Potential Imaging Biomarker for Predicting Survival in Patients With Cervical Cancer

Mendelian Randomization Study Supports Genetic Liability to Obsessive–Compulsive Disorder Associated With the Risk of Alzheimer's Disease

Cellular models of development of ovarian high‐grade serous carcinoma: A review of cell of origin and mechanisms of carcinogenesis

LPLUNC1 reduces glycolysis in nasopharyngeal carcinoma cells through the PHB1‐p53/c‐Myc axis

Circular RNA hsa_circ_0000467 promotes colorectal cancer progression by promoting eIF4A3-mediated c-Myc translation

CSF3 Is a Potential Drug Target for the Treatment of COVID-19

Editorial: Ovarian cancer-targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more

Identification and validation of an immune-related lncRNAs signature to predict the overall survival of ovarian cancer

The function of prohibitins in mitochondria and the clinical potentials

ZNF582 promoter methylation predicts cervical cancer radiosensitivity and ZNF582 protein overexpression reduces radiosensitivity by cell cycle arrest in S phase

The roles and molecular mechanisms of non-coding RNA in cancer metabolic reprogramming

Ferritinophagy: research advance and clinical significance in cancers

Suchergebnisse filtern